All Stories

  1. Sialic Acids and Cancer: Pathophysiological Association between Metastatic Progress and Treatment
  2. Anticancer Drug Development, Pharmaceutical Progress
  3. Human suicide, biomedical knowledge and therapeutic advances
  4. COVID-19 Research, Public Health and Biomedical Basis
  5. Anticancer Drug Development: Evaluative Architecture
  6. COVID-19 Study: A New Principle Discovery
  7. COVID-19 Study, Diagnostic and Therapeutic Transition
  8. Antimetastatic Drug, Pharmacologic Challenge and Opportunity
  9. Bone Metastasis Diagnosis, Blood Biomarker Detections
  10. Anti-metastatic drug development, overview and perspectives
  11. Educational Perspectives for Nursery
  12. Drug Sensitivity Testing for Cancer Therapy, Technique Analysis and Trends
  13. Pulmonary nodules, is there any pathogenesis evidence?
  14. HIV/AIDS Curability Study, Different Approaches and Drug Combination
  15. Pulmonary nodules, surgery or other medication
  16. Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
  17. Pulmonary Nodules, Surgery or Other Medication
  18. Anti-Metastatic Drug Developments, Utility of More Animal Models
  19. Several approaches for anticancer drug development progress
  20. Drug Sensitivity Testing for Cancer Therapy, Key Areas
  21. COVID-19 infection for metabolic abnormal human beings
  22. Fundamental knowledge for nurses 
  23. Nursery promotion, education and system updating
  24. Cancer Bone Metastasis, Diagnostic Insights and Drug Selection
  25. Cancer Bone Metastasis, Experimental Study
  26. Neuropsychiatric Approaches for Human Suicide Prediction and Management
  27. Osteoporosis Targeting, Possible Breakthroughs
  28. Neuropsychiatric insights for human suicide
  29. Bone Cancer and Metastasis Trials, Drug Treatment
  30. Neurobiology for human suicide
  31. Bone Disease Treatment Study, Major Pathways
  32. Pathology Study for Human Suicide
  33. Nursery activity and quality, chemistry between doctors and nurses
  34. Nursery education, narrow-range or wide-range
  35. Anticancer drug development, challenge and dilemma
  36. Life Origin on Earth, Knowledge Development
  37. HIV/AIDS treatment, therapeutic strategy break throughs
  38. Suicide Risks and Prevention, Neuropathogenic Study
  39. Medical Treatments for Chronic or Aggressive Diseases, Palliative Therapy and Nursery
  40. General information for nursery
  41. Historical analysis of suicide
  42. Drug sensitivity testing, a unique drug selection strategy
  43. Life Origin on Earth, Biochemical Approaches
  44. Herbal medicine in new era
  45. Nursery service, quality promotion
  46. Patient’s care and nursery in different diseases
  47. New HIV/AIDS Therapeutics
  48. Nursery Service in Modern Days
  49. Cancer Bioinformatics in Cancer Therapy
  50. Individualized Cancer Therapy
  51. Type 2 Diabetes Treatment and Drug Development Study
  52. Hypotheses for Life Origin on Earth, Comparison and Validation
  53. Type 2 Diabetes Study, Introduction and Perspective
  54. Anthocyanins and its biological & therapeutic characters
  55. A Critical Appraisal of Different Food Safety and Quality Management Tools to Accomplish Food Safety
  56. Pathology and treatments of obesity
  57. Obesity, Risks and Managements
  58. Keep up the pace of drug development evolution and expenditure
  59. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  60. Drug Combination in Clinical Cancer Treatments
  61. General outlook for individualized cancer therapy
  62. Ebola origin and treatment
  63. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
  64. HAART in HIV/AIDS Treatments
  65. Anticancer Drug Development, System Updating and Global Participations
  66. Life Origin on Earth, What is the Right Answer?
  67. Human suicide study, major disciplines and treatment outcomes
  68. Anticancer drug development
  69. HIV in Human Genomes and Therapeutics
  70. HIV Biotherapy and Natural Chemotherapeutic Agents
  71. Anticancer Drug Combinations, How Far We can Go Through?
  72. Antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot
  73. Life Origin on Earth, Insights among Different Arguments
  74. Cancer metastasis treatment, a key drawbacks
  75. The suicide treatment, a new model
  76. HIV Vaccine for Prevention and Cure, A Mission Possible
  77. Zika Therapy
  78. HIV vaccine
  79. Discover Natural Chemical Drugs in Modern Medicines
  80. Mathematics in biomedical science
  81. The origin of HIV
  82. Human suicide study
  83. Pharmacogenetics of Cancer Therapy
  84. Anticancer Drug Sensitivity Testing
  85. New Perspectives of HIV/AIDS Therapy Study
  86. Antidepressant treatment study
  87. Clinical neoplasm metastasis treatments according to patient's personal conditions.
  88. Assistant cancer treatments in the clinic
  89. Drug sensitivity testing in clinical cancer treatments
  90. Anticancer drug combination in the clinic
  91. Anticancer drug pharmacogenomics in cancer chemotherapy
  92. Cost-effectiveness for personalized cancer therapy
  93. Conclusion
  94. Introduction
  95. Discussion
  96. Cancer biomarker/bioinformatics detection in clinical cancer treatments
  97. Anti-diabetic treatments
  98. Anticancer Drug Combinational Study
  99. The Origins of HIV
  100. Anti-diabetic treatments, patho-therapeutic relation
  101. Origin of Ebola, hypothesis
  102. Personalized Cancer Therapy: A Perspective
  103. Pharmacogenomics in human suicide prediction and treatments
  104. Cancer metastasis treatment study and drug developments
  105. Challenge for HIV/AIDS therapy
  106. Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
  107. Drug Combinations in Cancer Treatments
  108. New Insights into Individualized Antimetastatic Therapy
  109. Anticancer drugs on serum sialic acid level in mice bearing LLC
  110. Genetics in Neural Toxicity of Drugs
  111. Avian flu, pathogenesis and therapeutic study
  112. First Genetic Information Replication in Life Origin on Earth
  113. Origins of Life, A New Cooperative Model
  114. Cancer Metastases and Clinical Therapies
  115. Origins of Life, RNA world or alternative RNA world
  116. Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
  117. Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
  118. Antimetastatic Therapies according to Metastatic Cascade
  119. Genetics in antidepressant-induced suicide
  120. Pathology of Drug-induced mania & suicide
  121. Influenza treatment
  122. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback
  123. Individualized cancer chemotherapy
  124. High Active Antiretroviral Therapy for HIV/AIDS-Early Intervention or Later Intervention?
  125. Genomic study of antidepressant-induced suicide
  126. Aberrant sialylation in tumor cells
  127. Anti-mobility of Bisdioxopiperanes against human mammary tumors
  128. Antimetastatic activity and mechanisms of action of Bisdioxopiperazine compounds
  129. Neural toxicity of drugs
  130. Anticancer activity and mechanisms of Bisdioxopiperazines
  131. Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
  132. 14C-probimane in the mice bearing LLC
  133. Unsatisfactory design of human AIDS genome research
  134. Antidepressant in Cancer Treatment
  135. AIDS and human genome studies, from a hypothesis to systematic approaches
  136. Antidepressants in Human suicide
  137. Mathematical model in therapeutic risk prediction
  138. Fibrinogen in neoplasm metastasis
  139. Sequencing the whole genome of infected human cells obtained from diseased patients – a proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases
  140. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study
  141. Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
  142. Individualized cancer chemotheray
  143. Anti-proliferative and chromosome segregation by probimane and MST-16
  144. Effect of Anti-Cancer Drugs on the Binding of 125I-Fibrinogen to Two Leukaemia Cell Lines In Vitro
  145. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
  146. Inhibition of probimane on lipid peroxidation of rabbit and human erythrocytes
  147. Aberration of sialylation in neoplasm metastasis and possible therapeutics
  148. Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
  149. Effect of magnetized water on the mice given high doses of antineoplastic drugs
  150. Inhibition of probimane on lipoperoxidation of human red cells in vitro
  151. Enzyme dynamic study on calmodulin Ca++-Mg++-ATPase system of red blood cells inhibited by α-anordrin and probimane
  152. Journal of Clinical and Medical Reviews